Search research articles
Contact Us
Filters
Showing results (51-60 of 95) with videos related to
Page
of 10
Sort By:
Journal of Endocrinological Investigation
|
February 1, 1983
Serum free thyroid hormones in T3-toxicosis: a study of 35 patients
C Ferrari, M Romussi, P Rampini, et al.
American Journal of Ophthalmology
|
May 15, 1990
Visual function improvement in patients with macroprolactinomas treated with bromocriptine
R L Lesser, J D Zheutlin, D Boghen, et al.
Investigative Ophthalmology
|
August 1, 1974
Velocity characteristics of normal human saccades
D Boghen, B T Troost, R B Daroff, et al.
European Journal of Endocrinology
|
October 1, 1995
Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature
J Bellone, L Ghizzoni, G Aimaretti, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1983
Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects
C Ferrari, C Barbieri, R Caldara, et al.
L'Union Medicale Du Canada
|
November 1, 1978
[Tomodensitometry of the orbit: study of 85 cases]
M Aubé, J Lesage, P Fauteux, et al.
Acta Endocrinologica
|
April 1, 1987
Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditis
C Ferrari, A Paracchi, E Parisio, et al.
Clinical Endocrinology
|
November 1, 1988
Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients
C Ferrari, A Paracchi, C Romano, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
June 1, 1993
Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?
E Ghigo, M Procopio, M Maccario, et al.
European Journal of Endocrinology
|
November 1, 1994
Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging
E Ghigo, E Arvat, G Rizzi, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 95) with videos related to
Sort By:
Page
of 10
Journal of Endocrinological Investigation
|
February 1, 1983
Serum free thyroid hormones in T3-toxicosis: a study of 35 patients
C Ferrari, M Romussi, P Rampini, et al.
American Journal of Ophthalmology
|
May 15, 1990
Visual function improvement in patients with macroprolactinomas treated with bromocriptine
R L Lesser, J D Zheutlin, D Boghen, et al.
Investigative Ophthalmology
|
August 1, 1974
Velocity characteristics of normal human saccades
D Boghen, B T Troost, R B Daroff, et al.
European Journal of Endocrinology
|
October 1, 1995
Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature
J Bellone, L Ghizzoni, G Aimaretti, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1983
Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects
C Ferrari, C Barbieri, R Caldara, et al.
L'Union Medicale Du Canada
|
November 1, 1978
[Tomodensitometry of the orbit: study of 85 cases]
M Aubé, J Lesage, P Fauteux, et al.
Acta Endocrinologica
|
April 1, 1987
Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditis
C Ferrari, A Paracchi, E Parisio, et al.
Clinical Endocrinology
|
November 1, 1988
Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients
C Ferrari, A Paracchi, C Romano, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
June 1, 1993
Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?
E Ghigo, M Procopio, M Maccario, et al.
European Journal of Endocrinology
|
November 1, 1994
Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging
E Ghigo, E Arvat, G Rizzi, et al.
Page
of 10